-+ 0.00%
-+ 0.00%
-+ 0.00%
Regentis wins EU approval for new GelrinC manufacturing process
Share
Listen to the news
Regentis wins EU approval for new GelrinC manufacturing process
  • Regentis won European Notified Body clearance for a next-generation, solvent-free GelrinC manufacturing process ahead of its Europe launch.
  • Process lifts production yield about 400%, delivering 5x more product per manufacturing volume, supporting scale-up and lowering costs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202607150900ACCESSWRNAPR_____1191322) on July 15, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending